RVC Investor Deep Dives (October)

When
Thursday, October 29, 2015
12:00 PM - 4:30 PM
Location
The Commons on Champa. 1245 Champa St. Denver, CO 80204
Spaces left
11

Registration

(depends on selected options)

Base fee:

Investor or Fund Manager (Member)
Investor or Fund Manager (non-member)

Registration is closed

RVC Investor Deep Dive

RVC has reserved this time the last Thursday of every month) for two companies to undergo the next step in the due diligence process.

The purpose of this meeting is to meet face-to-face with the company CEO and leadership in order to get crucial questions answered. The deep dive will take place in Denver and will cover all the major due diligence questions such as IP, competition, leadership, funding strategy, exit strategy, use of funds, milestones, etc.

The format for the Deep Dive will be as follows:

Company Pitch (5-10 minutes)

Q&A with Investors (1 hour, 20 minutes)

Private Investor Discussion (15 minutes)

Outstanding Questions w/ Company (15 minutes)

_____________________________________________

Deep Dive # 1

Time: 12:00-2:00pm
Company: Kalot Superfood

Kalot Superfood – is the fastest growing nut and seed butter company in the country and currently sell their almond butter and sunflower seed butter in over 1,000 retail locations nationwide. Customers include Whole Foods, Kroger, Sprouts, Hy-Vee, The Fresh Market, Vitamin Cottage, among others. Their mission is to provide ideal nutrition in easy to use formats to help their customers lead more fulfilling and healthier lives.
__________________________________________

Deep Dive #2
Time: 2:30-4:30pm

Company: AQ BioMed

AQ BioMed, LLC is a privately held biomedical device company located in Boulder, CO. AQ Medical has made new discoveries about how cells respond to chemical interactions and physical forces caused by biomedical implants. Using this knowledge they developed the AQ BioMed implant, the Oculieve shunt, which is used to prevent blindness due to over-pressurization. The AQ BioMed implant has entered into the $3B glaucoma shunt market, has over 15 years of R&D and is protected by 6 patents.

__________________________________________

To attend, you must be an accredited investor (net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 together with his or her spouse if married] and have the expectation to make the same amount this year). We do not require a minimum investment.